| Ortho Tri-Cyclen Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Ortho Tri-Cyclen triphasic 35 mcg | tablet | oral | 1.0 each | OTC |
| Ortho Tri-Cyclen triphasic 35 mcg | tablet | oral | 0.0 - | OTC |
Posted by hollybeht25 about 1 year ago
I have been on ortho tri-cyclen for 7 months. I have noticed a difference in my moods. I am a lot more emotional now and my...
Posted by fg2704 about 1 year ago
I am reading this thread and will, as a male, caution everyone about the possible effects of Ortho Tri-Cyclen Lo. I am 41, ha...
Posted by suewoo about 1 year ago
I am 20 years old I have had an irregular period since I first got it at 12 and extremely bad problems with cramps, so my doc...
Students face rise in Pill prices - Stanford Daily
Ortho Tri-Cyclen Lo has quintupled in price — from $10 to $50 per month. Those with outside insurance plans may get reimbursed, however. ...
Tue Mar 04 04:24:55 -0500 2008
Causes of Acne and Acne Treatment - American Chronicle
Oral contraceptives, including a combination of norgestimate and ethinyl estradiol (Ortho-Cyclen, Ortho Tri-Cyclen), have been shown to improve acne in ...
Fri Feb 22 15:49:34 -0500 2008
Kroger joins rivals on low-price generics: Grocer's $4 ... - Therapeutics Daily (subscription) (press release)
Generic versions of oral contraceptives Ortho Cyclen and Ortho Tri Cyclen, as well as one fertility drug, will cost $9. Kroger is by no means the first to ...
Thu Feb 07 07:17:08 -0500 2008
ethinyl estradiol - A semisynthetic estrogen. Ethinyl estradiol binds to the estrogen receptor complex and enters the nucleus, activating DNA transcription of genes involved in estrogenic cellular responses. This agent also inhibits 5-alpha reductase in epididymal tissue, which lowers testosterone levels and may delay progression of prostatic cancer. In addition to its antineoplastic effects, ethinyl estradiol protects against osteoporosis. In animal models, short-term therapy with this agent has been shown to provide long-term protection against breast cancer, mimicking the antitumor effects of pregnancy. (NCI04)
norgestimate